Independent and Joint Association of Statin Therapy with Adverse Outcomes in Heart Failure Patients with Atrial Fibrillation Treated with Cardiac Resynchronization Therapy

References

• Glikson M, Nielsen JC, Kronborg MB, et al. 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy. Eur Heart J. 2021;42(35):3427–3520. doi:10.1093/eurheartj/ehab364
   PubMed Web of Science ®Google Scholar
• Patel N, Viles-Gonzalez J, Agnihotri K, et al. Frequency of in-hospital adverse outcomes and cost utilization associated with cardiac resynchronization therapy defibrillator implantation in the United States. J Cardiovasc Electrophysiol. 2018;29(10):1425–1435. doi:10.1111/jce.13701
   PubMed Web of Science ®Google Scholar
• Khan NK, Goode KM, Cleland JG, et al. Prevalence of ECG abnormalities in an international survey of patients with suspected or confirmed heart failure at death or discharge. Eur J Heart Fail. 2007;9(5):491–501. doi:10.1016/j.ejheart.2006.11.003
   PubMed Web of Science ®Google Scholar
• Prinzen FW, Vernooy K, Auricchio A. Cardiac resynchronization therapy: state-of-the-art of current applications, guidelines, ongoing trials, and areas of controversy. Circulation. 2013;128(22):2407–2418. doi:10.1161/CIRCULATIONAHA.112.000112
   PubMed Web of Science ®Google Scholar
• Daubert JC, Saxon L, Adamson PB, et al. 2012 EHRA/HRS expert consensus statement on cardiac resynchronization therapy in heart failure: implant and follow-up recommendations and management. Heart Rhythm. 2012;9(9):1524–1576. doi:10.1016/j.hrthm.2012.07.025
   PubMed Web of Science ®Google Scholar
• Wilton SB, Leung AA, Ghali WA, Faris P, Exner DV. Outcomes of cardiac resynchronization therapy in patients with versus those without atrial fibrillation: a systematic review and meta-analysis. Heart Rhythm. 2011;8(7):1088–1094. doi:10.1016/j.hrthm.2011.02.014
   PubMed Web of Science ®Google Scholar
• Pinho-Gomes AC, Reilly S, Brandes RP, Casadei B. Targeting inflammation and oxidative stress in atrial fibrillation: role of 3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibition with statins. Antioxid Redox Signal. 2014;20(8):1268–1285. doi:10.1089/ars.2013.5542
   PubMed Web of Science ®Google Scholar
• Liakopoulos OJ, Choi YH, Haldenwang PL, et al. Impact of preoperative statin therapy on adverse postoperative outcomes in patients undergoing cardiac surgery: a meta-analysis of over 30,000 patients. Eur Heart J. 2008;29(12):1548–1559. doi:10.1093/eurheartj/ehn198
   PubMed Web of Science ®Google Scholar
• Fauchier L, Pierre B, de Labriolle A, Grimard C, Zannad N, Babuty D. Antiarrhythmic effect of statin therapy and atrial fibrillation a meta-analysis of randomized controlled trials. J Am Coll Cardiol. 2008;51(8):828–835. doi:10.1016/j.jacc.2007.09.063
   PubMed Web of Science ®Google Scholar
• O’Regan C, Wu P, Arora P, Perri D, Mills EJ. Statin therapy in stroke prevention: a meta-analysis involving 121,000 patients. Am J Med. 2008;121(1):24–33. doi:10.1016/j.amjmed.2007.06.033
   PubMed Web of Science ®Google Scholar
• Goldberger JJ, Subacius H, Schaechter A, et al. Effects of statin therapy on arrhythmic events and survival in patients with nonischemic dilated cardiomyopathy. J Am Coll Cardiol. 2006;48(6):1228–1233. doi:10.1016/j.jacc.2006.05.053
   PubMed Web of Science ®Google Scholar
• Buber J, Goldenberg I, Moss AJ, et al. Reduction in life-threatening ventricular tachyarrhythmias in statin-treated patients with nonischemic cardiomyopathy enrolled in the MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy). J Am Coll Cardiol. 2012;60(8):749–755. doi:10.1016/j.jacc.2012.03.041
   PubMed Web of Science ®Google Scholar
• Bašinskas P, Stoškutė N, Gerulytė A, Abramavičiūtė A, Puodžiukynas A, Kazakevičius T. Prognostication of poor survival after cardiac resynchronization therapy. Medicina. 2020;56(1):19. doi:10.3390/medicina56010019
   PubMed Web of Science ®Google Scholar
• Hanna IR, Heeke B, Bush H, et al. Lipid-lowering drug use is associated with reduced prevalence of atrial fibrillation in patients with left ventricular systolic dysfunction. Heart Rhythm. 2006;3(8):881–886. doi:10.1016/j.hrthm.2006.05.010
   PubMed Web of Science ®Google Scholar
• Cameron A, Schwartz MJ, Kronmal RA, Kosinski AS. Prevalence and significance of atrial fibrillation in coronary artery disease (CASS Registry). Am J Cardiol. 1988;61(10):714–717. doi:10.1016/0002-9149(88)91053-3
   PubMed Web of Science ®Google Scholar
• Proietti M, Laroche C, Nyvad O, et al. Use of statins and adverse outcomes in patients with atrial fibrillation: an analysis from the EURObservational Research Programme Atrial Fibrillation (EORP-AF) general registry pilot phase. Int J Cardiol. 2017;248:166–172. doi:10.1016/j.ijcard.2017.08.055
   PubMed Web of Science ®Google Scholar
• Zhang N, Cai M, Hua W, et al. Prognostic effects of longitudinal changes in left ventricular ejection fraction with cardiac resynchronization therapy. ESC Heart Fail. 2021;8(1):368–379. doi:10.1002/ehf2.13082
   PubMed Web of Science ®Google Scholar
• World Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310(20):2191–2194. doi:10.1001/jama.2013.281053
   PubMed Web of Science ®Google Scholar
• January CT, Wann LS, Calkins H, et al. 2019 AHA/ACC/HRS focused update of the 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons. Circulation. 2019;140(2):e125–e151. doi:10.1161/CIR.0000000000000665
   PubMed Web of Science ®Google Scholar
• Arnett DK, Blumenthal RS, Albert MA, et al. 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines. Circulation. 2019;140(11):e596–e646. doi:10.1161/CIR.0000000000000678
   PubMed Web of Science ®Google Scholar
• Stone GW, Maehara A, Lansky AJ, et al. A prospective natural-history study of coronary atherosclerosis. N Engl J Med. 2011;364(3):226–235. doi:10.1056/NEJMoa1002358
   PubMed Web of Science ®Google Scholar
• Barbour SJ, Coppo R, Zhang H, et al. Evaluating a new international risk-prediction tool in IgA nephropathy. JAMA Intern Med. 2019;179(7):942–952. doi:10.1001/jamainternmed.2019.0600
   PubMed Web of Science ®Google Scholar
• Maisel WH, Stevenson LW. Atrial fibrillation in heart failure: epidemiology, pathophysiology, and rationale for therapy. Am J Cardiol. 2003;91(6a):2d–8d. doi:10.1016/S0002-9149(02)03373-8
   PubMed Web of Science ®Google Scholar
• Brignole M, Pentimalli F, Palmisano P, et al. AV junction ablation and cardiac resynchronization for patients with permanent atrial fibrillation and narrow QRS: the APAF-CRT mortality trial. Eur Heart J. 2021;42(46):4731–4739. doi:10.1093/eurheartj/ehab569
   PubMed Web of Science ®Google Scholar
• Paraskevas KI, Athyros VG, Briana DD, Kakafika AI, Karagiannis A, Mikhailidis DP. Statins exert multiple beneficial effects on patients undergoing percutaneous revascularization procedures. Curr Drug Targets. 2007;8(8):942–951. doi:10.2174/138945007781386893
   PubMed Web of Science ®Google Scholar
• Zheng Z, Jayaram R, Jiang L, et al. Perioperative rosuvastatin in cardiac surgery. N Engl J Med. 2016;374(18):1744–1753. doi:10.1056/NEJMoa1507750
   PubMed Web of Science ®Google Scholar
• Abuissa H, O’Keefe JH, Bybee KA. Statins as anti-arrhythmics: a systematic review part II: effects on risk of ventricular arrhythmias. Clin Cardiol. 2009;32(10):549–552. doi:10.1002/clc.20435
   PubMed Web of Science ®Google Scholar
• Rezaei Y, Gholami-Fesharaki M, Dehghani MR, Arya A, Haghjoo M, Arjmand N. Statin antiarrhythmic effect on atrial fibrillation in statin-naive patients undergoing cardiac surgery: a meta-analysis of randomized controlled trials. J Cardiovasc Pharmacol Ther. 2016;21(2):167–176. doi:10.1177/1074248415602557
   PubMed Web of Science ®Google Scholar
• Fang WT, Li HJ, Zhang H, Jiang S. The role of statin therapy in the prevention of atrial fibrillation: a meta-analysis of randomized controlled trials. Br J Clin Pharmacol. 2012;74(5):744–756. doi:10.1111/j.1365-2125.2012.04258.x
   PubMed Web of Science ®Google Scholar
• Liu T, Li L, Korantzopoulos P, Liu E, Li G. Statin use and development of atrial fibrillation: a systematic review and meta-analysis of randomized clinical trials and observational studies. Int J Cardiol. 2008;126(2):160–170. doi:10.1016/j.ijcard.2007.07.137
   PubMed Web of Science ®Google Scholar
• Fauchier L, Clementy N, Babuty D. Statin therapy and atrial fibrillation: systematic review and updated meta-analysis of published randomized controlled trials. Curr Opin Cardiol. 2013;28(1):7–18. doi:10.1097/HCO.0b013e32835b0956
   PubMed Web of Science ®Google Scholar
• Sumner AD, Boehmer JP, Saxon LA, et al. Statin use is associated with improved survival in patients with advanced heart failure receiving resynchronization therapy. Congest Heart Fail. 2009;15(4):159–164. doi:10.1111/j.1751-7133.2009.00057.x
   PubMedGoogle Scholar
• Birnie D, Hudnall H, Lemke B, et al. Continuous optimization of cardiac resynchronization therapy reduces atrial fibrillation in heart failure patients: results of the Adaptive Cardiac Resynchronization Therapy Trial. Heart Rhythm. 2017;14(12):1820–1825. doi:10.1016/j.hrthm.2017.08.017
   PubMed Web of Science ®Google Scholar
• Reilly SN, Jayaram R, Nahar K, et al. Atrial sources of reactive oxygen species vary with the duration and substrate of atrial fibrillation: implications for the antiarrhythmic effect of statins. Circulation. 2011;124(10):1107–1117. doi:10.1161/CIRCULATIONAHA.111.029223
   PubMed Web of Science ®Google Scholar
• Anter E, Jessup M, Callans DJ. Atrial fibrillation and heart failure: treatment considerations for a dual epidemic. Circulation. 2009;119(18):2516–2525. doi:10.1161/CIRCULATIONAHA.108.821306
   PubMed Web of Science ®Google Scholar
• Carlisle MA, Fudim M, DeVore AD, Piccini JP. Heart failure and atrial fibrillation, like fire and fury. JACC Heart Fail. 2019;7(6):447–456. doi:10.1016/j.jchf.2019.03.005
   PubMed Web of Science ®Google Scholar
• Ousdigian KT, Borek PP, Koehler JL, Heywood JT, Ziegler PD, Wilkoff BL. The epidemic of inadequate biventricular pacing in patients with persistent or permanent atrial fibrillation and its association with mortality. Circ Arrhythm Electrophysiol. 2014;7(3):370–376. doi:10.1161/CIRCEP.113.001212
   PubMed Web of Science ®Google Scholar
• Ruwald MH, Mittal S, Ruwald AC, et al. Association between frequency of atrial and ventricular ectopic beats and biventricular pacing percentage and outcomes in patients with cardiac resynchronization therapy. J Am Coll Cardiol. 2014;64(10):971–981. doi:10.1016/j.jacc.2014.06.1177
   PubMed Web of Science ®Google Scholar
• Rauch U, Osende JI, Chesebro JH, et al. Statins and cardiovascular diseases: the multiple effects of lipid-lowering therapy by statins. Atherosclerosis. 2000;153(1):181–189. doi:10.1016/S0021-9150(00)00397-X
   PubMed Web of Science ®Google Scholar
• Dorsch MP, Lester CA, Ding Y, Joseph M, Brook RD. Effects of race on statin prescribing for primary prevention with high atherosclerotic cardiovascular disease risk in a large healthcare system. J Am Heart Assoc. 2019;8(22):e014709. doi:10.1161/JAHA.119.014709
   PubMed Web of Science ®Google Scholar
• Kanwal F, Hernaez R, Liu Y, et al. Factors associated with access to and receipt of liver transplantation in veterans with end-stage liver disease. JAMA Intern Med. 2021;181(7):949–959. doi:10.1001/jamainternmed.2021.2051
   PubMed Web of Science ®Google Scholar